Clincosm LogoSign in Get a demo

An Evaluation of California's Experiment With HOPE

Sponsor
Pepperdine University (Other)
Overall Status
Completed
CT.gov ID
NCT01237691
Collaborator
University of California, Irvine (Other), University of California, Los Angeles (Other)
105
Enrollment
1
Location
2
Arms
28
Actual Duration (Months)
3.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: HOPE supervision
  • Behavioral: Parole-as-usual
 N/A

Detailed Description

The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
105 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Phase 1 Study of California's HOPE Experiment
Actual Study Start Date :
Nov 1, 2010
Actual Primary Completion Date :
Oct 1, 2012
Actual Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: HOPE supervision

Parolee supervised under California's new HOPE parole model.

Behavioral: HOPE supervision
HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.
Other Names:
  • HOPE
  • COPE

    		•
    Active Comparator: Parole-as-usual

    Parolees supervised under California parole-as-usual.

    Behavioral: Parole-as-usual
    Parolees are supervised under standard parole supervision practice in California.
    Other Names:
  • Routine parole

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Days incarcerated [24 months]

      Total number of days incarcerated in jail or prison

    Secondary Outcome Measures

    1. % positive drug tests [24 months]

      Percentage of random and scheduled drug tests that test positive for illicit drugs

    2. %Missed [24 months]

      Percentage of parole appointments that are missed.

    3. Revocation rate [24 months]

      Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge.

    4. New arrests [24 months]

      Number of new arrests.

    5. Perceptions of risk of detection [24 months]

      Parolees perceived risk of detection for drug use

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Assigned to the Sacramento Metro IV Parole Unit.

    • Released from a term of return-to-custody for a violation for, or involving, the use of drugs.

    • Have a maximum controlling discharge date at least one year from the date of release from the return-to-custody term.

    Exclusion Criteria:
    • History of convictions for crimes that require registration under Penal Code Section

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sacramento Metro IV Parole Unit. Sacramento California United States 95811

    Sponsors and Collaborators

    • Pepperdine University
    • University of California, Irvine
    • University of California, Los Angeles

    Investigators

    • Principal Investigator: Angela Hawken, PhD, Pepperdine University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pepperdine University
    ClinicalTrials.gov Identifier:
    NCT01237691
    Other Study ID Numbers:
    • SPPN1110F01
    First Posted:
    Nov 9, 2010
    Last Update Posted:
    Apr 10, 2018
    Last Verified:
    Apr 1, 2018
    Keywords provided by Pepperdine University
    drug use
    drug arrests
    incarceration

    Study Results

    No Results Posted as of Apr 10, 2018